NanoViricides, Inc.
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-8.2M | $-9.5M | $-8.3M | $-8.6M | $-8.1M | $-8.8M | $-13.4M | $-8.4M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $517.0K | $735.5K | $750.7K | $739.3K | $715.1K | $696.3K | $691.5K | $687.6K |
| Amortization | $8.3K | $8.3K | $8.3K | $8.3K | $8.3K | $8.3K | $8.3K | $8.3K |
| Stock-Based Compensation | — | — | — | — | — | — | — | $35.8K |
| Net Cash from Operating Activities | $-7.7M | $-8.5M | $-6.3M | $-5.7M | $-5.9M | $-8.2M | $-6.7M | $-6.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $84.3K | $57.0K | $156.6K | $151.7K | $324.3K | $238.8K | $8.6K | $73.8K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-84.3K | $-57.0K | $-156.6K | $-151.7K | $-324.3K | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $9.0M | $5.3M | $3.1M | $-94.8K | $-234.7K | $15.3M | $17.8M | $2.4M |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-7.8M | $-8.5M | $-6.5M | $-5.8M | $-6.2M | $-8.5M | $-6.7M | $-6.9M |